Trailing Twelve Months Revenue Growth: Simulations Plus, Inc. (SLP)

Simulations Plus, Inc. (SLP) is developing a cloud-based biomodeling environment by integrating AI tools into laboratory research cycles. The rolling annual sales growth rate visualizes this process, with the 2.10 level serving as a critical benchmark. The business is scaling globally, generating profit through the sale of digital licenses. Strong FDA loyalty and GastroPlus's status as an industry standard guarantee a steady influx of B2B clients.

This indicator reflects business expansion dynamics by measuring the relative change in revenue over the last twelve months compared to the same period last year to assess organic growth rates. By analyzing the year-over-year sales growth percentage for TTM, an investor can see the resilience of demand for biosimulation software, which, as a digital product without physical logistics, provides Simulations Plus, Inc. (SLP) independence from geopolitical disruptions and sanctions.